Search

Gimv NV

Chiusa

SettoreFinanza

46.35 3.23

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

44.5

Massimo

46.35

Metriche Chiave

By Trading Economics

Entrata

127M

Vendite

-49M

65M

P/E

Media del settore

7.821

28.186

EPS

3.4

Rendimento da dividendi

5.68

Margine di Profitto

195.239

Dipendenti

94

EBITDA

52M

128M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

5.68%

4.24%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

77M

1.7B

Apertura precedente

43.12

Chiusura precedente

46.35

Notizie sul Sentiment di mercato

By Acuity

50%

50%

180 / 493 Classifica in Finance

Gimv NV Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 gen 2026, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 gen 2026, 00:00 UTC

Utili

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 gen 2026, 23:47 UTC

Discorsi di Mercato

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 gen 2026, 23:44 UTC

Discorsi di Mercato

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 gen 2026, 23:39 UTC

Discorsi di Mercato

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 gen 2026, 23:32 UTC

Discorsi di Mercato

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 gen 2026, 22:56 UTC

Acquisizioni, Fusioni, Takeovers

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 gen 2026, 22:53 UTC

Acquisizioni, Fusioni, Takeovers

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 gen 2026, 22:17 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

14 gen 2026, 22:17 UTC

Discorsi di Mercato

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 gen 2026, 22:09 UTC

Utili

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 gen 2026, 22:08 UTC

Utili

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 gen 2026, 21:53 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 gen 2026, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Announces Positive Profit Alert for 2025

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Citigroup Acting as Financial Advisor to WuXi XDC

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 gen 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 gen 2026, 21:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

14 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

14 gen 2026, 21:49 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 gen 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

WuXi XDC Makes Cash Offer for BioDlink International

14 gen 2026, 21:13 UTC

Discorsi di Mercato

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 gen 2026, 20:30 UTC

Discorsi di Mercato
Utili

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 gen 2026, 20:13 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 gen 2026, 20:08 UTC

Discorsi di Mercato

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 gen 2026, 19:33 UTC

Discorsi di Mercato

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 gen 2026, 19:06 UTC

Discorsi di Mercato
Utili

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Gimv NV Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

180 / 493 Classifica in Finanza

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat